A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers

PLoS One. 2013;8(1):e55212. doi: 10.1371/journal.pone.0055212. Epub 2013 Jan 31.

Abstract

Primary erythromelalgia (PE) is an autosomal dominant neurological disorder characterized by severe burning pain and erythema in the extremities upon heat stimuli or exercise. Mutations in human SCN9A gene, encoding the α-subunit of the voltage-gated sodium channel, Na(v)1.7, were found to be responsible for PE. Three missense mutations of SCN9A gene have recently been identified in Taiwanese patients including a familial (I136V) and two sporadic mutations (I848T, V1316A). V1316A is a novel mutation and has not been characterized yet. Topologically, I136V is located in DI/S1 segment and both I848T and V1316A are located in S4-S5 linker region of DII and DIII domains, respectively. To characterize the elelctrophysiological manifestations, the channel conductance with whole-cell patch clamp was recorded on the over-expressed Chinese hamster overy cells. As compared with wild type, the mutant channels showed a significant hyperpolarizing shift in voltage dependent activation and a depolarizing shift in steady-state fast inactivation. The recovery time from channel inactivation is faster in the mutant than in the wild type channels. Since warmth can trigger and exacerbate symptoms, we then examine the influence of tempearture on the sodium channel conduction. At 35°C, I136V and V1316A mutant channels exhibit a further hyperpolarizing shift at activation as compared with wild type channel, even though wild type channel also produced a significant hyperpolarizing shift compared to that of 25°C. High temperature caused a significant depolarizing shift in steady-state fast inactivation in all three mutant channels. These findings may confer to the hyperexcitability of sensory neurons, especially at high temperature. In order to identifying an effective treatment, we tested the IC₅₀ values of selective sodium channel blockers, lidocaine and mexiletine. The IC₅₀ for mexiletine is lower for I848T mutant channel as compared to that of the wild type and other two mutants which is comparable to the clinical observations.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Base Sequence
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Drug Resistance / physiology*
  • Erythromelalgia / drug therapy*
  • Erythromelalgia / genetics*
  • Erythromelalgia / pathology
  • Female
  • Genes, Dominant / genetics
  • Humans
  • Inhibitory Concentration 50
  • Molecular Sequence Data
  • Mutation, Missense / genetics
  • NAV1.7 Voltage-Gated Sodium Channel / genetics*
  • Patch-Clamp Techniques
  • Sequence Analysis, DNA
  • Sodium Channel Blockers / pharmacology*
  • Taiwan
  • Temperature
  • Transfection

Substances

  • NAV1.7 Voltage-Gated Sodium Channel
  • SCN9A protein, human
  • Sodium Channel Blockers

Grants and funding

This work was supported by a grant from Institute of Biomedical Sciecnes, Academia Sinica (IBMS-CRC96-P03) and National Science Council (NSC-99-3112-B-002-012) of Taiwanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.